Products
Biosimilars
Brand Name Image INN Therapeutic Areas More information
- NameRemsima®
-
- INNInfliximab
- IndicationsRheumatology, Gastroenterology, Dermatology
- Approved By EMA(EU) Medicines.ie
- NameRemsima® SC
-
- INNInfliximab
- IndicationsRheumatology, Gastroenterology, Dermatology
- Approved By EMA(EU) Medicines.ie
- NameYuflyma®
-
- INNAdalimumab
- IndicationsRheumatology, Gastroenterology, Dermatology
- Approved By EMA(EU) Medicines.ie
- NameSteqeyma®▼
-
- INNUstekinumab
- IndicationsRheumatology, Gastroenterology, Dermatology
- Approved By EMA(EU) Medicines.ie
This product description is for medical and educational purposes only and not intended to promote the product. For more details, please consult a doctor, nurse or pharmacist.
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly to HPRA Pharmacovigilance via www.hpra.ie/report, or directly to Celltrion by emailing medinfoIE@celltrionhc.com or calling (01) 564 5074.
By reporting side effects you can help provide more information on the safety of medicines.
INN, international non-proprietary name
Novel Therapeutics
Brand Name Image INN Therapeutic Areas More information
This product description is for medical and educational purposes only and not intended to promote the product. For more details, please consult a doctor, nurse or pharmacist.
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. If you get any side effects talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly to HPRA Pharmacovigilance via www.hpra.ie/report, or directly to Celltrion by emailing medinfoIE@celltrionhc.com or calling (01) 564 5074.
By reporting side effects you can help provide more information on the safety of medicines.
INN, international non-proprietary name